Roybal Centers for Translational Research on Dementia Care Provider Support (P30 - Clinical Trial Required)
Funding Opportunity RFA-AG-19-007 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits Edward R. Roybal Centers for translational intervention development research for Alzheimers Disease and Alzheimers Disease related dementias care provider support. The purpose of the Roybal Centers is to develop behavioral interventions that improve the health, well-being and/or capacity of individuals and/or systems that provide care to persons with AD-ADRD. Roybal Centers will conduct Stage 0 through IV pilot studies in accordance with the multidirectional, translational NIH Stage Model, ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 7, 2018 Category: Research Source Type: funding
Notice of Expiration of PA-18-473 "Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R15 Clinical Trial Not Allowed)"
Notice NOT-NR-18-010 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 9, 2018 Category: Research Source Type: funding
In Vivo Synaptic Function in Alzheimers Disease and Related Dementias (R21 Clinical Trial Not Allowed)
Funding Opportunity PAR-18-760 from the NIH Guide for Grants and Contracts. To study in vivo synaptic structure and function in Alzheimer's and related dementia; and to advance development of methods to study synapses in animal models and humans. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 18, 2018 Category: Research Source Type: funding
Informational Webinar for Alzheimer's Disease Related Dementia (ADRD) Funding Opportunity Announcements (FOAs) for PAR-18-661, RFA-NS-18-015, RFA-NS-18-025 and RFA-NS-18-024
Notice NOT-NS-18-050 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 15, 2018 Category: Research Source Type: funding
Notice Of Change in Application Due Date for RFA-NS-18-024 "Lewy Body Dementia Center Without Walls (CWOW) (U54 Clinical Trial not Allowed)"
Notice NOT-NS-18-047 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 28, 2018 Category: Research Source Type: funding
Towards Implementing Novel Training Methods to Enhance Cognition in Aging (U01 Clinical Trial Required)
Funding Opportunity RFA-AG-18-031 from the NIH Guide for Grants and Contracts. This RFA invites applications for planning awards to develop and finalize protocols for well-powered cognitive training intervention trials to remediate or prevent age-related cognitive decline as well as possibly prevent or delay the onset of mild cognitive impairment and dementia. Planning activities may include the collection of pilot data and the refinement of cognitive training protocols consistent with Stage I of the NIH Stage Model. Trial designs must justify the means used to assess cognition and to explore the underlying mechanisms o...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 14, 2018 Category: Research Source Type: funding
Lewy Body Dementia Center Without Walls (CWOW) (U54 Clinical Trial Not Allowed)
Funding Opportunity RFA-NS-18-024 from the NIH Guide for Grants and Contracts. This FOA invites applications that will systematically and comprehensively characterize alpha-synuclein and amyloid-beta subspecies present in human Lewy Body Dementia (LBD) post-mortem brain tissue, identify toxic subspecies and potential mechanisms of toxicity, and characterize any interactions between the proteins that may contribute to increased toxicity and/or explain selective vulnerabilities of cells/circuits. Applications are required to include at least 3 hypothesis-driven projects that address these goals, an administrative core, an...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 9, 2018 Category: Research Source Type: funding
Dementia Care and Caregiver Support Interventions (R01 - Clinical Trial Required)
Funding Opportunity RFA-AG-18-030 from the NIH Guide for Grants and Contracts. The over-arching purpose of this FOA is to help to lay the groundwork for pragmatic trials and real-world implementation of Alzheimers disease and related dementias (ADRD) care and caregiving interventions by supporting early-Stage (Stage I, II, III of the NIH Stage Model) behavioral intervention development clinical trials aimed at adapting/modifying interventions for the real world, examining the principles underlying these interventions, developing methods to ensure real-world fidelity of delivery, and developing training procedures for th...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 5, 2018 Category: Research Source Type: funding
Assistive Technology for Persons with Alzheimer's Disease and Related Dementias and Their Caregivers (R41/R42 - Clinical Trials Optional)
Funding Opportunity PAR-18-587 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage Small Business Innovation Research (SBIR) research and development of assistive technology for individuals with Alzheimer's disease and related dementias (ADRD) and their caregivers/care partners, to enhance their health and well-being, reduce illness and disability, and improve quality of life. Particularly of interest are technologies for providing psychosocial support (enhancing mood, mitigating the effects of loneliness, and enhancing social connection and communicati...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 26, 2018 Category: Research Source Type: funding
Assistive Technology for Persons with Alzheimer's Disease and Related Dementias and Their Caregivers (R43/R44 - Clinical Trial Optional)
Funding Opportunity PAR-18-588 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage Small Business Innovation Research (SBIR) research and development of assistive technology for individuals with Alzheimer's disease and related dementias (ADRD) and their caregivers/care partners, to enhance their health and well-being, reduce illness and disability, and improve quality of life. Particularly of interest are technologies for providing psychosocial support (enhancing mood, mitigating the effects of loneliness, and enhancing social connection and communicati...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 26, 2018 Category: Research Source Type: funding
Alzheimer's Disease Research Centers (P30 - Clinical Trials Not Allowed)
Funding Opportunity RFA-AG-19-001 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for P30 Alzheimer's Disease Research Centers. NIA-designated Alzheimer's Disease Research Centers (ADRCs) serve as major sources of discovery into the nature of Alzheimers disease (AD) and related dementias and into the development of more effective approaches to prevention, diagnosis, care, and therapy. They contribute significantly to the development of shared resources that support dementia-relevant research, and they collaborate and coordinate their research efforts with oth...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 25, 2018 Category: Research Source Type: funding
Pragmatic Trials for Dementia Care in Long-term Services and Support (LTSS) Settings (R61/R33 - Clinical Trial Required)
Funding Opportunity PAR-18-585 from the NIH Guide for Grants and Contracts. This FOA invites applications for pragmatic trials for dementia care in Long-term Services and Support (LTSS) settings which will: (1) be designed to address practical comparative questions faced by Alzheimers disease (AD) and Alzheimers disease and related dementia (ADRD) patients, clinicians, and caregivers (both paid and unpaid); (2) include broad and diverse populations; and (3) be conducted in real-world settings. These trials are intended to produce results that can be directly adopted by healthcare providers, patients or caregivers for ra...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 24, 2018 Category: Research Source Type: funding
Testing Lifespan-Healthspan-Extension Interventions in the Models of Alzheimers Disease (AD/ADRD) (R41/R42 Clinical Trial Not Allowed)
Funding Opportunity PAR-18-514 from the NIH Guide for Grants and Contracts. This funding opportunity (FOA) encourages small business-based (STTR) research and development of commercial pharmaceutical interventions to extend lifespan and/or healthspan, to prevent, treat, and/or slow the progression of symptoms associated with Alzheimer's disease (AD) and Alzheimer's disease related dementia (ADRD) in human cells and/or tissue, in-vitro models, and/or non-human animals. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 20, 2017 Category: Research Source Type: funding
Testing Lifespan/Healthspan-Extension Interventions in the Models of Alzheimers Disease (AD/ADRD) (R43/R44 Clinical Trial Not Allowed)
Funding Opportunity PAR-18-512 from the NIH Guide for Grants and Contracts. This funding opportunity (FOA) encourages small business-based (SBIR) research and development of commercial pharmaceutical interventions to extend lifespan and/or healthspan, to prevent, treat, and/or slow the progression of symptoms associated with Alzheimer's disease (AD) and Alzheimer's disease related dementia (ADRD) in human cells and/or tissue, in-vitro models, and/or non-human animals. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 20, 2017 Category: Research Source Type: funding
Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R01 Clinical Trial Optional)
Funding Opportunity PA-18-348 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to stimulate clinical research focused on biobehavioral or technological interventions to attenuate cognitive decline in individuals with dementia (such as Alzheimers disease, Lewy body dementia, vascular dementia), mild cognitive impairment (MCI), or disease- or age-related cognitive decline. There is particular interest in interventions that can be implemented in community settings by the affected individual, informal caregivers, or others in the community. Research to inform the dev...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 18, 2017 Category: Research Source Type: funding
